SCHEMBL5738768

SCHEMBL5738768

Cc1ccc2[nH]c3c(cc(-c4cc[n+]([O-])cc4)c(=O)n3C)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.37
▸ ALDH1A1 P00352 9/20 0.37
▸ HPGD P15428 6/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ POLB P06746 2/20 0.35
▸ HSD17B10 Q99714 6/20 0.35
▸ TP53 P04637 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CA12 O43570 2/20 0.34
▸ CA1 P00915 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3867849 0.85 KDM4E (0.50) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2383613 0.84 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2382552 0.83 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6281112 0.83 KDM4E (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2383709 0.83 KDM4E (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2381110 0.83 MAPK1 (0.43) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL3444475 0.83 ACHE (0.46) KDM4EALDH1A1HPGDMEN1KMT2A
Hydrochloric Acid SCHEMBL3445384 0.82 ACHE (0.45) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2383356 0.81 ALDH1A1 (0.43) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2384546 0.79 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556380-B1 PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN THE 3-POSITION BY A HETEROCYCLIC GROUP, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI AVENTIS (FR) 2006-04-12 — — EP claimed
EP-1556380-A1 PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN THE 3-POSITION BY A HETEROCYCLIC GROUP, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS Sanofi-Aventis (FR) 2005-07-27 — — EP claimed
WO-2004037821-A1 PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN THE 3-POSITION BY A HETEROCYCLIC GROUP, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2004-05-06 — — WO claimed
EP-1556380-B1 PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN THE 3-POSITION BY A HETEROCYCLIC GROUP, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI AVENTIS (FR) 2006-04-12 — — EP disclosed
EP-1556380-A1 PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN THE 3-POSITION BY A HETEROCYCLIC GROUP, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS Sanofi-Aventis (FR) 2005-07-27 — — EP disclosed
WO-2004037821-A1 PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN THE 3-POSITION BY A HETEROCYCLIC GROUP, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2004-05-06 — — WO disclosed
Send feedback